Explore MyBioSource's premium PCR kits for disease detection and genetic research, offering fast, accurate results for oncology, infectious diseases, and more.

Indore: Amid the ongoing water contamination crisis in Bhagirathpura locality, which has claimed multiple lives and affected ...

PCR-based techniques have transformed how scientists analyze transcripts’ translational applications in cancer and ...

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

Honeybees are vital to global food security, yet colony collapse threatens ecosystems and agriculture worldwide.   Discover ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

A new review highlights major advances in a promising class of diagnostic tools known as aptamer-based biosensors, which ...

CoDiagnostics secures its first patent for the Co-Dx PCR platform in Australia, strengthening IP protection as the point-of-care system awaits regulatory clearance.

The lab, which expands upon an effort by UCSD and Scripps Research, will use wastewater analysis to detect flu, COVID and RSV ...

This valuable study identifies a novel regulator of stress-induced gene quiescence in C. elegans: the multi-Zinc-finger protein ZNF-236. The work provides evidence for an active mechanism that ...

According to MarketsandMarkets™, the Genomic Biomarkers Market is projected to grow from about USD 29.00 billion in 2025 to ...

Analyze the bullish trends and strategies for Nifty and Nifty Bank futures amid key support levels for potential rebounds.